EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NYSE Amex: AIS) today reported financial and operating results for the fourth quarter and year ended December 31, 2008 and outlined key objectives for 2009. For the quarter ended December 31, 2008, the Company reported a net loss of $2.7 million, or $0.04 per share, compared to a net loss of $3.2 million, or $0.05 per share for the same period in 2007. For the year ended December 31, 2008, the Company reported a net loss of $12.7 million, or $0.19 per share, compared to a net loss of $8.6 million, or $0.14 per share, for 2007. At December 31, 2008, Antares had approximately $13.1 million in cash.
